摘要
目的分析外周血管介入治疗大咯血的疗效和安全性。方法选取2017年8月至2021年8月郑州市第三人民医院大咯血患者148例,按随机数字表法分为A组和B组,每组74例。B组采取常规治疗,A组采取外周血管介入治疗。对比两组疗效、不良反应及复发率。结果A组总有效率[97.30%(72/74)]较B组[85.14%(63/74)]高(P<0.05)。A组不良反应发生率[4.05%(3/74)]较B组[13.51%(10/74)]低(P<0.05)。A组复发率[2.70%(2/74)]较B组[16.22%(12/74)]低(P<0.05)。结论外周血管介入治疗大咯血患者具有良好临床效果和安全性,并可降低复发率,改善预后。
Objective To analyze the efficacy and safety of peripheral vascular intervention in the treatment of massive hemoptysis.Methods A total of 148 patients with massive hemoptysis in Zhengzhou Third People’s Hospital from August 2017 to August 2021 were selected.They were randomly divided into group A and group B,with 74 cases in each groups.Group B was treated with routine treatment and group A was treated with peripheral vascular intervention.The curative effects,adverse reactions and recurrence rates of the two groups were compared.Results The total effective rate of group A[97.30%(72/74)]was higher than that[85.14%(63/74)]in group B(P<0.05).The incidence of adverse reactions in group A[4.05%(3/74)]was lower than that[13.51%(10/74)]in group B(P<0.05).The recurrence rate of group A[2.70%(2/74)]was lower than that of group B[16.22%(12/74)](P<0.05).Conclusions Peripheral vascular interventional therapy for patients with massive hemoptysis has good clinical effect and safety,which can reduce the recurrence rate and improve the prognosis.
作者
张丹阳
Zhang Danyang(Department of Interventional Medicine,Zhengzhou Third People’s Hospital,Zhengzhou 450000,China)
出处
《临床医学》
CAS
2022年第4期21-23,共3页
Clinical Medicine
关键词
大咯血
疗效
不良反应
外周血管介入
复发率
Massive hemoptysis
Curative effect
Adverse reactions
Peripheral vascular intervention
Recurrence rate